Hosted on MSN43m
Elite Pharmaceuticals Reports Decline in Q3 2025 Earnings
Elite Pharmaceuticals ( ($ELTP) ) has released its Q3 earnings. Here is a breakdown of the information Elite Pharmaceuticals presented to its ...
How many members of Congress receive money from pharmaceutical company PACs?
Top Republican recipients of contributions from employees or PACS associated with the pharmaceutical/health products ...
StockStory.org on MSN1d
Why West Pharmaceutical Services (WST) Stock Is Nosediving
Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the ...
West Pharmaceutical Stock Sinks On Weaker Than Expected 2025 Guidance
West Pharmaceutical reported Q4 earnings and revenue above expectations but issued a weak 2025 forecast. William Blair ...
STAT10d
No, Bernie Sanders and Elizabeth Warren aren’t top recipients of pharmaceutical industry donations
A quirk in the website OpenSecrets has given RFK Jr. a chance to misleadingly portray Sen. Bernie Sanders as receiving big ...
West Pharmaceutical forecasts 2025 results below expectations, shares drop
West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...
Pharma distributor, generic drug trade groups express concern over tariffs
Trade groups representing pharma distributors and generic/biosimilar industries express concerns over potential tariffs on ...
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...